4.06.2021
1.26.2021
Arcellx Appoints Rami Elghandour as Chairman and Chief Executive Officer
12.07.2020
Arcellx CART-ddBCMA Cell Therapy Demonstrates Deep and Durable Responses in the Treatment of Relapsed and Refractory Multiple Myeloma
11.05.2020
Arcellx Announces Clinical Data to be Presented at the 62nd American Society of Hematology (ASH) Annual Meeting
10.02.2020